Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3356) 3356
Book Chapter (152) 152
Dissertation (25) 25
Conference Proceeding (7) 7
Publication (4) 4
Paper (3) 3
Book / eBook (2) 2
Journal / eJournal (2) 2
Book Review (1) 1
Magazine Article (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2005) 2005
life sciences & biomedicine (1991) 1991
humans (1764) 1764
atypical antipsychotics (1727) 1727
schizophrenia (1279) 1279
psychiatry (1241) 1241
male (1192) 1192
antipsychotic agents - therapeutic use (1116) 1116
female (981) 981
biological and medical sciences (902) 902
medical sciences (889) 889
pharmacology & pharmacy (863) 863
adult (814) 814
pharmacology. drug treatments (775) 775
antipsychotic agents - adverse effects (741) 741
neurosciences & neurology (727) 727
schizophrenia - drug therapy (724) 724
atypical antipsychotic (710) 710
psychology. psychoanalysis. psychiatry (684) 684
psychopharmacology (644) 644
middle aged (640) 640
neuropharmacology (599) 599
neurosciences (567) 567
psycholeptics: tranquillizer, neuroleptic (499) 499
olanzapine (492) 492
clinical neurology (444) 444
antipsychotic drugs (428) 428
treatment outcome (409) 409
risperidone (403) 403
animals (400) 400
antipsychotic agents - pharmacology (392) 392
clozapine (365) 365
aged (340) 340
psychopathology. psychiatry (325) 325
adolescent (323) 323
antipsychotic agents - administration & dosage (317) 317
drug therapy (316) 316
bipolar disorder (297) 297
adult and adolescent clinical studies (289) 289
quetiapine (281) 281
risperidone - therapeutic use (276) 276
psychotropic drugs (263) 263
rats (242) 242
dose-response relationship, drug (240) 240
psychotic disorders - drug therapy (233) 233
quetiapine fumarate (232) 232
atypical (220) 220
psychiatric status rating scales (212) 212
psychoses (205) 205
neuroleptics (200) 200
aripiprazole (199) 199
dopamine (196) 196
benzodiazepines - therapeutic use (195) 195
bipolar disorder - drug therapy (188) 188
analysis (187) 187
double-blind method (175) 175
benzodiazepines (174) 174
psychosis (173) 173
young adult (172) 172
retrospective studies (171) 171
risperidone - adverse effects (170) 170
antipsychotics (168) 168
mental disorders (168) 168
schizophrenic psychology (168) 168
drugs (160) 160
dibenzothiazepines - therapeutic use (159) 159
risk factors (158) 158
antidepressants (157) 157
drug therapy, combination (148) 148
depression (145) 145
comorbidity (144) 144
piperazines - therapeutic use (143) 143
atypical neuroleptics (142) 142
psychology (142) 142
ptsd (140) 140
randomized controlled trials as topic (140) 140
clozapine - pharmacology (139) 139
time factors (137) 137
neurology (136) 136
general & internal medicine (135) 135
serotonin (135) 135
social sciences (135) 135
antipsychotic (134) 134
medicine, general & internal (134) 134
care and treatment (131) 131
clozapine - therapeutic use (127) 127
atypical antipsychotic drugs (120) 120
benzodiazepines - adverse effects (116) 116
haloperidol (116) 116
medicine & public health (114) 114
rats, sprague-dawley (113) 113
side effects (112) 112
weight gain (112) 112
clinical trials (111) 111
pirenzepine - analogs & derivatives (110) 110
dementia (108) 108
diabetes (108) 108
child (107) 107
antipsychotic agents (102) 102
ziprasidone (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3248) 3248
French (69) 69
German (69) 69
Italian (41) 41
Spanish (41) 41
Turkish (33) 33
Portuguese (20) 20
Russian (18) 18
Japanese (17) 17
Czech (15) 15
Dutch (11) 11
Polish (9) 9
Korean (3) 3
Persian (3) 3
Slovak (3) 3
Chinese (2) 2
Croatian (2) 2
Hungarian (1) 1
Icelandic (1) 1
Norwegian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia: Number Needed to Harm
by Maust, Donovan T and Kim, Hyungjin Myra and Seyfried, Lisa S and Chiang, Claire and Kavanagh, Janet and Schneider, Lon S and Kales, Helen C
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
Life Sciences & Biomedicine | Psychiatry | Science & Technology | United States - epidemiology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Risk | Case-Control Studies | Dose-Response Relationship, Drug | Psychotropic Drugs - adverse effects | Dibenzothiazepines - adverse effects | Risperidone - adverse effects | Female | Registries | Retrospective Studies | Dementia - drug therapy | Quetiapine Fumarate | Veterans - psychology | Psychotropic Drugs - administration & dosage | Haloperidol - adverse effects | Dementia - mortality | Antipsychotic Agents - administration & dosage | Aged | Benzodiazepines - adverse effects | Veterans - statistics & numerical data | Antidepressive Agents - adverse effects | Dosage and administration | Antipsychotic drugs | Mortality | Analysis | Risk factors | Dementia | Veterans | Comorbidity | Americans | Survivors | Outpatient Treatment | Longitudinal Study | Psychiatric Disorders | Epidemiology | Benzodiazepines | Conventional Antipsychotics | Anticonvulsants | Cognitive Disorders | Etiology | Psychopharmacology | Opioids | Aging | Antidepressant Drugs | Atypical Antipsychotics | PTSD (ICD-9) | Negative Therapeutic Reaction | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. The effects of antipsychotics on the brain: What have we learnt from structural imaging of schizophrenia? - A systematic review
by Smieskova, R and Fusar-Poli, P and Allen, P and Bendfeldt, K and Stieglitz, R.D and Drewe, J and Radue, E.W and McGuire, P.K and Riecher-Rössler, A and Borgwardt, S.J
Current pharmaceutical design, ISSN 1381-6128, 2009, Volume 15, Issue 22, pp. 2535 - 2549
Neuroimaging | Antipsychotics | Typical | Atypical neuroleptics | MRI | Schizophrenia | Conventional | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Brain - drug effects | Antipsychotic Agents - therapeutic use | Humans | Brain - pathology | Magnetic Resonance Imaging - methods | Clinical Trials as Topic | Schizophrenia - pathology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy
Journal Article
Details down arrow
3. Full Text Antipsychotics for treatment of delirium in hospitalised non‐ICU patients
by Burry, Lisa and Mehta, Sangeeta and Perreault, Marc M and Luxenberg, Jay S and Siddiqi, Najma and Hutton, Brian and Fergusson, Dean A and Bell, Chaim and Rose, Louise and Burry, Lisa
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 06/2018, Volume 2018, Issue 6, pp. CD005594 - CD005594
Delirium | Atypical antipsychotics | Olanzapine | Pharmacological Interventions | Placebo Effect | Mental health | Hospitalization | Haloperidol | Benzodiazepines | Randomized Controlled Trials as Topic | Neurology | Antipsychotic Agents | Risperidone | Medicine General & Introductory Medical Sciences | Antipsychotic Agents - adverse effects | Humans | Haloperidol - therapeutic use | Male | Haloperidol - adverse effects | Delirium - drug therapy | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Risperidone - adverse effects | Adult | Female | Benzodiazepines - adverse effects | Delirium - mortality | Benzodiazepines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Do atypical antipsychotics really enhance smoking reduction more than typical ones?: The effects of antipsychotics on smoking reduction in patients with schizophrenia
by Wu, Bo-Jian and Chen, Hsing-Kang and Lee, Shin-Min
Journal of clinical psychopharmacology, ISSN 0271-0749, 06/2013, Volume 33, Issue 3, pp. 319 - 328
clozapine | smoking reduction | schizophrenia | nicotine replacement therapy | atypical antipsychotics | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Tobacco smoking | Schizophrenia | Biological and medical sciences | Medical sciences | Neuropharmacology | Psycholeptics: tranquillizer, neuroleptic | Toxicology | Psychoses | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Addictive behaviors | Tobacco, tobacco smoking | Nicotine - administration & dosage | Nicotine - therapeutic use | Humans | Middle Aged | Linear Models | Male | Smoking Cessation - methods | Smoking Prevention | Bupropion - administration & dosage | Dose-Response Relationship, Drug | Antipsychotic Agents - therapeutic use | Smoking - epidemiology | Tobacco Use Cessation Products | Adult | Female | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Bupropion - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Unresolved issues for utilization of atypical antipsychotics in schizophrenia: Antipsychotic polypharmacy and metabolic syndrome
by Jeon, Sang Won and Kim, Yong-Ku
International journal of molecular sciences, ISSN 1661-6596, 10/2017, Volume 18, Issue 10, p. 2174
Schizophrenia | Atypical antipsychotics | Treatment resistance | Polypharmacy | Metabolic syndrome | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Neuroleptics | Mental disorders | Clozapine | Metabolism | Patients | Neurotransmitter receptors | Quality of life | Psychotropic drugs | Glucose metabolism | Side effects | Receptors | Lipid metabolism | Metabolic disorders | Index Medicus | metabolic syndrome | schizophrenia | atypical antipsychotics | polypharmacy | treatment resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Atypical antipsychotics for disruptive behaviour disorders in children and youths
by Loy, Jik H and Merry, Sally N and Hetrick, Sarah E and Stasiak, Karolina and Loy, Jik H
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD008559 - CD008559
Developmental, psychosocial & learning problems | Piperazines | Atypical defiance | Aggression | Quetiapine Fumarate | Attention Deficit Disorder with Hyperactivity | Antisocial behaviour and conduct disorders | PSYCHOSOCIAL PROBLEMS | Randomized Controlled Trials as Topic | Dibenzothiazepines | Antipsychotic Agents | Anxiety Disorders | Conduct Disorder | Thiazoles | Child health | Depressive Disorder, Major | Risperidone | Weight Gain | Medicine General & Introductory Medical Sciences | Drug interventions | Developmental, psychosocial, and learning problems | Attention Deficit and Disruptive Behavior Disorders | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Conduct Disorder - drug therapy | Antipsychotic Agents - adverse effects | Humans | Child, Preschool | Piperazines - therapeutic use | Thiazoles - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Quetiapine Fumarate - therapeutic use | Attention Deficit and Disruptive Behavior Disorders - drug therapy | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Dibenzothiazepines - adverse effects | Adolescent | Risperidone - adverse effects | Anxiety Disorders - drug therapy | Aggression - drug effects | Child | Depressive Disorder, Major - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Olanzapine versus other atypical antipsychotics for schizophrenia
by Komossa, Katja and Rummel‐Kluge, Christine and Hunger, Heike and Schmid, Franziska and Schwarz, Sandra and Duggan, Lorna and Kissling, Werner and Leucht, Stefan and Komossa, Katja
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2013, Issue 5, pp. CD006654 - CD006654
Drugs | Costs | Olanzapine | Piperazines | Anti‐psychotics | Quetiapine Fumarate | Mental health | Amisulpride | Schizophrenia | Clozapine | Aripiprazole | Insurance medicine | Sulpiride | Benzodiazepines | Quinolones | Dibenzothiazepines | Schizophrenia & psychosis | Antipsychotic Agents | Thiazoles | General | Antipsychotic medication: atypical | Risperidone | Medicine General & Introductory Medical Sciences | Clinical care ‐ by treatment category | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clozapine - therapeutic use | Sulpiride - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Piperazines - therapeutic use | Thiazoles - therapeutic use | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Schizophrenia - drug therapy | Benzodiazepines - therapeutic use | Index Medicus
Journal Article